Everolimus News and Research

RSS
Lab-grown miniature blood vessels mimic rare Hutchinson-Gilford Progeria Syndrome

Lab-grown miniature blood vessels mimic rare Hutchinson-Gilford Progeria Syndrome

Novartis to collaborate with IBM Watson Health for improving outcomes in advanced breast cancer

Novartis to collaborate with IBM Watson Health for improving outcomes in advanced breast cancer

Liver transplant patients who take new anti-rejection drug gain less weight, study finds

Liver transplant patients who take new anti-rejection drug gain less weight, study finds

Stents can be as effective as surgery for many patients with left main coronary artery disease

Stents can be as effective as surgery for many patients with left main coronary artery disease

ATS releases new clinical practice guidelines for diagnosis, management of LAM

ATS releases new clinical practice guidelines for diagnosis, management of LAM

New generation drug eluting stents show lower efficacy than contemporary BMS, study shows

New generation drug eluting stents show lower efficacy than contemporary BMS, study shows

New drug provides considerable added benefit in treating adults with advanced renal cell cancer

New drug provides considerable added benefit in treating adults with advanced renal cell cancer

FDA approves Absorb GT1 BVS to treat coronary artery disease

FDA approves Absorb GT1 BVS to treat coronary artery disease

Neoadjuvant endocrine therapy 'a reasonable option' for ER-positive breast cancer

Neoadjuvant endocrine therapy 'a reasonable option' for ER-positive breast cancer

Everolimus combined with standard R-CHOP therapy shows promise in treating DLBCL patients

Everolimus combined with standard R-CHOP therapy shows promise in treating DLBCL patients

Everolimus-eluting bioresorbable vascular scaffold shows promise in PAD

Everolimus-eluting bioresorbable vascular scaffold shows promise in PAD

Cabozantinib extends advanced RCC overall survival

Cabozantinib extends advanced RCC overall survival

Post PCI symmetry important for good clinical outcome

Post PCI symmetry important for good clinical outcome

New research reveals advances that could change gynecologic cancer standard-of-care treatments

New research reveals advances that could change gynecologic cancer standard-of-care treatments

FDA approves additional indication for Eisai's anticancer agent Lenvima in combo with Everolimus for advanced renal cell carcinoma

FDA approves additional indication for Eisai's anticancer agent Lenvima in combo with Everolimus for advanced renal cell carcinoma

New development offers hope to patients with inoperable advanced midgut neuroendocrine cancer

New development offers hope to patients with inoperable advanced midgut neuroendocrine cancer

Novartis announces FDA approval of Afinitor for progressive, nonfunctional neuroendocrine tumors of GI

Novartis announces FDA approval of Afinitor for progressive, nonfunctional neuroendocrine tumors of GI

Sunitinib versus everolimus trial highlights non-clear cell RCC patient response heterogeneity

Sunitinib versus everolimus trial highlights non-clear cell RCC patient response heterogeneity

Chi-Med announces initiation of Phase III sulfatinib registration trial in patients with NETs in China

Chi-Med announces initiation of Phase III sulfatinib registration trial in patients with NETs in China

New MSK-led studies on liquid biopsy presented at San Antonio Breast Cancer Symposium

New MSK-led studies on liquid biopsy presented at San Antonio Breast Cancer Symposium